| A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle (NCT05304390) | Fred Hutchinson Cancer Center | 2022-06-06 |
| Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer (NCT05075759) | Fred Hutchinson Cancer Center | 2022-06-06 |
| NT-I7 for Kaposi Sarcoma in Patients With or Without HIV (NCT04893018) | Fred Hutchinson Cancer Center | 2022-05-23 |
| Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes (NCT03399773) | Fred Hutchinson Cancer Center | 2022-05-10 |
| mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation (NCT04525222) | Fred Hutchinson Cancer Center | 2022-05-09 |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) (NCT04965597) | Fred Hutchinson Cancer Center | 2022-04-19 |
| Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers (NCT04260776) | Fred Hutchinson Cancer Center | 2022-04-15 |
| The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study) (NCT05250037) | Fred Hutchinson Cancer Center | 2022-03-30 |
| Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya (NCT04982250) | Fred Hutchinson Cancer Center | 2022-02-24 |
| Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study (NCT05135650) | Fred Hutchinson Cancer Center | 2022-01-25 |
| Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy (NCT04359784) | Fred Hutchinson Cancer Center | 2021-12-27 |
| Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (NCT04809766) | Fred Hutchinson Cancer Center | 2021-12-14 |
| Red and Processed Meat Effects on the Metabolome and Microbiome (NCT05274906) | Fred Hutchinson Cancer Center | 2021-11-16 |
| Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study (NCT04870515) | Fred Hutchinson Cancer Center | 2021-11-04 |
| eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors (NCT04081298) | Fred Hutchinson Cancer Center | 2021-09-16 |
| Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study (NCT04922697) | Fred Hutchinson Cancer Center | 2021-09-15 |
| CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease (NCT04526288) | Fred Hutchinson Cancer Center | 2021-08-09 |
| Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer (NCT04639245) | Fred Hutchinson Cancer Center | 2021-07-19 |
| Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking (NCT04409236) | Fred Hutchinson Cancer Center | 2021-07-19 |
| Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis (NCT04706507) | Fred Hutchinson Cancer Center | 2021-06-29 |
| Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation (NCT03602898) | Fred Hutchinson Cancer Center | 2021-06-01 |
| An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis (NCT04259788) | Fred Hutchinson Cancer Center | 2021-05-24 |
| Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant (NCT04572815) | Fred Hutchinson Cancer Center | 2021-05-14 |
| Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study (NCT04447313) | Fred Hutchinson Cancer Center | 2021-03-05 |
| Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis (NCT04370301) | Fred Hutchinson Cancer Center | 2021-02-09 |
| Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV (NCT04682301) | Fred Hutchinson Cancer Center | 2021-02-05 |
| Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans (NCT04502524) | Fred Hutchinson Cancer Center | 2021-02-03 |
| Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study (NCT04660331) | Fred Hutchinson Cancer Center | 2021-02-01 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies (NCT04195633) | Fred Hutchinson Cancer Center | 2021-01-25 |
| Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma (NCT03986502) | Fred Hutchinson Cancer Center | 2021-01-22 |
| Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer (NCT04496219) | Fred Hutchinson Cancer Center | 2021-01-22 |
| Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer (NCT04211766) | Fred Hutchinson Cancer Center | 2021-01-05 |
| PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning (NCT04889144) | Fred Hutchinson Cancer Center | 2021-01-01 |
| Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis (NCT04384692) | Fred Hutchinson Cancer Center | 2020-12-18 |
| Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease (NCT04198922) | Fred Hutchinson Cancer Center | 2020-12-11 |
| CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia (NCT04375631) | Fred Hutchinson Cancer Center | 2020-12-03 |
| Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization (NCT04208724) | Fred Hutchinson Cancer Center | 2020-11-18 |
| Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant (NCT03125070) | Fred Hutchinson Cancer Center | 2020-10-29 |
| Vaccine Responsiveness After CAR-T Cell Therapy (NCT04410900) | Fred Hutchinson Cancer Center | 2020-08-03 |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach (NCT04902144) | Fred Hutchinson Cancer Center | 2020-08-03 |
| Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study (NCT04431479) | Fred Hutchinson Cancer Center | 2020-06-29 |
| Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases (NCT04083183) | Fred Hutchinson Cancer Center | 2020-06-16 |
| CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients (NCT04195945) | Fred Hutchinson Cancer Center | 2020-05-27 |
| Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers (NCT04194918) | Fred Hutchinson Cancer Center | 2020-05-18 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors (NCT04200482) | Fred Hutchinson Cancer Center | 2020-02-21 |
| Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study (NCT04081779) | Fred Hutchinson Cancer Center | 2020-02-19 |
| Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant (NCT03807063) | Fred Hutchinson Cancer Center | 2020-01-02 |
| Glasdegib for Chronic Graft-Versus-Host Disease (NCT04111497) | Fred Hutchinson Cancer Center | 2019-12-03 |
| Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants (NCT04062955) | Fred Hutchinson Cancer Center | 2019-10-28 |
| Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda (NCT03864419) | Fred Hutchinson Cancer Center | 2019-10-24 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas (NCT03670069) | Fred Hutchinson Cancer Center | 2019-09-30 |
| Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study (NCT04188912) | Fred Hutchinson Cancer Center | 2019-09-13 |
| Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY (NCT04060849) | Fred Hutchinson Cancer Center | 2019-09-03 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant (NCT03779854) | Fred Hutchinson Cancer Center | 2019-08-29 |
| Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases (NCT03870750) | Fred Hutchinson Cancer Center | 2019-08-15 |
| Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial (NCT03778021) | Fred Hutchinson Cancer Center | 2019-08-05 |
| 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966) | Fred Hutchinson Cancer Center | 2019-07-10 |
| Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer (NCT03747484) | Fred Hutchinson Cancer Center | 2019-07-03 |
| Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors (NCT03781778) | Fred Hutchinson Cancer Center | 2019-05-07 |
| Acute Exercise Intervention in Breast Cancer Survivors (NCT03779867) | Fred Hutchinson Cancer Center | 2019-03-25 |
| Reducing Insulin, Growth Hormones, and Tumors (NCT03785808) | Fred Hutchinson Cancer Center | 2018-12-21 |
| Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study (NCT04254133) | Fred Hutchinson Cancer Center | 2018-11-30 |
| Resistance Training Program and Cardiovascular Exercise in Increasing Muscle Mass in Adolescent and Young Adult Stem Cell Transplant Survivors (NCT03672981) | Fred Hutchinson Cancer Center | 2018-11-21 |
| A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort (NCT03731637) | Fred Hutchinson Cancer Center | 2018-10-15 |
| Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot) (NCT03585231) | Fred Hutchinson Cancer Center | 2018-09-17 |
| Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm (NCT03531918) | Fred Hutchinson Cancer Center | 2018-09-14 |
| Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer (NCT03238703) | Fred Hutchinson Cancer Center | 2018-09-01 |
| SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart (NCT03574012) | Fred Hutchinson Cancer Center | 2018-08-31 |
| Pilot Trial of a Telephone Weight Loss, Nutrition, Exercise Study (NCT03738540) | Fred Hutchinson Cancer Center | 2018-08-29 |
| Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia (NCT03515707) | Fred Hutchinson Cancer Center | 2018-07-10 |
| Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma (NCT03397186) | Fred Hutchinson Cancer Center | 2018-06-19 |
| Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease (NCT03483675) | Fred Hutchinson Cancer Center | 2018-06-06 |
| Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer (NCT03518242) | Fred Hutchinson Cancer Center | 2018-06-06 |
| BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma (NCT03502577) | Fred Hutchinson Cancer Center | 2018-05-23 |
| Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers (NCT03525106) | Fred Hutchinson Cancer Center | 2018-05-18 |
| Glucosamine and Chondroitin in Gut in Preventing People From Inflammation (NCT03963323) | Fred Hutchinson Cancer Center | 2018-05-11 |
| Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors (NCT03523195) | Fred Hutchinson Cancer Center | 2018-04-18 |
| Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma (NCT03338959) | Fred Hutchinson Cancer Center | 2018-03-28 |
| HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant (NCT03326921) | Fred Hutchinson Cancer Center | 2018-02-23 |
| A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas (NCT03277729) | Fred Hutchinson Cancer Center | 2017-12-05 |
| Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma (NCT03338972) | Fred Hutchinson Cancer Center | 2017-11-29 |
| Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers (NCT03775616) | Fred Hutchinson Cancer Center | 2017-11-15 |
| Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia (NCT02770820) | Fred Hutchinson Cancer Center | 2017-11-06 |
| huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia (NCT03103971) | Fred Hutchinson Cancer Center | 2017-11-03 |
| 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia (NCT03128034) | Fred Hutchinson Cancer Center | 2017-10-24 |
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT03074318) | Fred Hutchinson Cancer Center | 2017-09-28 |
| Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation (NCT03246906) | Fred Hutchinson Cancer Center | 2017-09-11 |